John Canepa Insider Profile

4 Followers
John Canepa, Director at Harvard Apparatus Regenerative Technology, holds 10.13K shares in Candel Therapeutics (Ticker: CADL), holds 1.77K shares in Harvard Apparatus Regenerative Technology (Ticker: HRGN). Most recently, John Canepa Bought ― shares of Candel Therapeutics on Aug 02, 2021 for an estimated value of 81.00K.
tipranks
John Canepa

John Canepa
Harvard Apparatus Regenerative Technology (HRGN)
Director

Ranked #86,751 out of 98,123 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-68.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$72K
93.69%
6.31%
A breakdown of John Canepa's holdings

Insider Roles

Candel Therapeutics
(CADL)
CFO
Harvard Apparatus Regenerative Technology
(HRGN)
Director
Roles that John Canepa holds in companies

Most Profitable Insider Trade

Stock:
Candel Therapeutics
(CADL)
Rating:Informative Buy
Date:Aug 02, 2021 - Aug 02, 2022
Return:-56.00%
The most profitable trade made by John Canepa

John Canepa's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Harvard Apparatus Regenerative Technology
Mar 28, 2018
Director
Uninformative Buy
2.94K
$4.57K
Candel Therapeutics
Aug 02, 2021
CFO
Informative Buy
81.00K
$67.84K
List of latest transactions for each holding click on a transaction to see John Canepa's performance on stock

John Canepa insider profile FAQ

What is the percentage of profitable transactions made by John Canepa?
The percentage of profitable transactions made by John Canepa is 0%.
    What is the average return per transaction made by John Canepa?
    The average return per transaction made by John Canepa is -68.60%.
      What stocks does John Canepa hold?
      John Canepa holds: HRGN, CADL stocks.
        What was John Canepa’s latest transaction?
        John Canepa latest transaction was an Informative Buy of $81.00K.
          What was John Canepa's most profitable transaction?
          John Canepa’s most profitable transaction was an Informative Buy of CADL stock on August 2, 2021. The return on the trade was -56.00%.
            What is John Canepa's role in Harvard Apparatus Regenerative Technology?
            John Canepa's role in Harvard Apparatus Regenerative Technology is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.